Use of TOGA expression profiling to identify drug targets in CNS injury

被引:0
|
作者
Ellison, JA [1 ]
机构
[1] Digital Gene Technol Inc, La Jolla, CA USA
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
引用
收藏
页码:53 / 53
页数:1
相关论文
共 50 条
  • [21] Gene Expression Profiling for Discovery of Novel Targets in Human Traumatic Brain Injury
    Barr, Taura L.
    Alexander, Sheila
    Conley, Yvette
    BIOLOGICAL RESEARCH FOR NURSING, 2011, 13 (02) : 140 - 153
  • [22] PDEs as drug targets for CNS immune disorders
    Hebb, Andrea L. O.
    Robertson, Harold A.
    CURRENT OPINION IN INVESTIGATIONAL DRUGS, 2008, 9 (07) : 744 - 753
  • [23] Muscarinic acetylcholine receptors as CNS drug targets
    Langmead, Christopher J.
    Watson, Jeannette
    Reavill, Charlie
    PHARMACOLOGY & THERAPEUTICS, 2008, 117 (02) : 232 - 243
  • [24] CART Peptides as Targets for CNS Drug Development
    Hunter, Richard G.
    Kuhar, Michael J.
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2003, 2 (03) : 201 - 205
  • [25] NOX ENZYMES AS DRUG TARGETS IN CNS DISEASES
    Krause, Karl-Heinz
    FREE RADICAL BIOLOGY AND MEDICINE, 2013, 65 : S4 - S4
  • [26] Histamine Pharmacology and New CNS Drug Targets
    Tiligada, Ekaterini
    Kyriakidis, Konstantinos
    Chazot, Paul L.
    Passani, M. Beatrice
    CNS NEUROSCIENCE & THERAPEUTICS, 2011, 17 (06) : 620 - 628
  • [27] Depressed or Demented: Common CNS Drug Targets? !
    Sun, Miao-Kun
    Alkon, Daniel L.
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2002, 1 (06) : 575 - 592
  • [28] Neuroimmunophilins as novel targets for CNS drug discovery
    Hamilton, GS
    Ross, DT
    Valentine, H
    Guo, H
    Connolly, MA
    Liang, S
    Ramsey, C
    Li, J
    Huang, W
    Wei, L
    Howorth, P
    Soni, R
    Fuller, M
    Sauer, H
    Nowotnick, A
    Suzdak, PD
    Steiner, JP
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1997, 213 : 172 - MEDI
  • [29] Integrated miRNA and mRNA expression profiling to identify mRNA targets of dysregulated miRNAs in pulmonary tuberculosis
    Zhang, Xing
    Zhu, Min
    Hu, Xiaolong
    EPIGENOMICS, 2018, 10 (08) : 1051 - 1069
  • [30] Proteomic profiling to identify therapeutics targets in glioblastoma (GBM).
    Thyparambil, Sheeno P.
    Liao, Wei-Li
    An, Eunkyung
    Bhalkikar, Anuja
    Heaton, Robert
    Sylvester, Karl G.
    Ling, Xuefeng B.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)